Genomic deletions explain why some types of melanoma resist targeted therapies
Credit score: CC0 Public Area Melanoma is the deadliest type of pores and skin most cancers. With international incidence charges ...
Tag: Therapies
Key mechanism governing bone marrow stem cells opens door to new therapies
Credit score: Pixabay/CC0 Public Area A key mechanism controlling how bone marrow stem cells work has been revealed in a ...
Analyzing tissue-agnostic therapies for the treatment of primary brain tumors
Credit score: Anna Shvets from Pexels Researchers from Miami Most cancers Institute, a part of Baptist Well being South Florida, ...
Newly discovered genetic mutation protects against Parkinson’s disease and offers hope for new therapies
Credit score: Unsplash/CC0 Public Area A beforehand unidentified genetic mutation in a small protein offers important safety towards Parkinson's illness ...
Analyzing how cancer mutations interact may improve targeted therapies
Trajectories of the somatic evolution by mutation of TP53, KRAS, LRP1B, and STK11, inferred from a complete of 565 whole-exome ...
New form of immunotherapy under investigation for cancer that resists conventional T cell therapies
Axial CT picture with i.v. distinction. Macrocystic adenocarcinoma of the pancreatic head. Credit score: public area Medical investigators are theorizing ...
Behind the approvals—decades of research lead to a new generation of targeted cancer therapies
Credit score: Pixabay/CC0 Public Area Final month, the U.S. Meals and Drug Administration (FDA) authorized the usage of the drug ...
The role of p53 as a target for novel cancer therapies
Complicated interaction between TP53-mutant most cancers cells and their microenvironment. Credit score: Nature Opinions Medical Oncology (2023). DOI: 10.1038/s41571-023-00842-2 The ...
Key mechanisms of action differences in immune checkpoint inhibitor combination therapies for advanced melanoma
Proposed mechanism of the 2 ICI combos. Graphic created with Biorender (biorender.com). ICI, immune checkpoint inhibitor. Credit score: Journal for ...
Studies suggest novel targeted therapies may benefit patients with metastatic HR+/ HER2- breast cancer
Credit score: Pixabay/CC0 Public Area Two research led by researchers at The College of Texas MD Anderson Most cancers Middle ...